BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reha J, Mukkamalla SKR, Rathore R, Somasundar PS. Adequate lymph node evaluation in the elderly is associated with improved survival in patients with stage I–III colon cancer: A validation study using the National Cancer Data Base. European Journal of Surgical Oncology 2018;44:148-56. [DOI: 10.1016/j.ejso.2017.11.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Salas M, Henderson M, Sundararajan M, Tu N, Islam Z, Ebeid M, Horne L. Use of comorbidity indices in patients with any cancer, breast cancer, and human epidermal growth factor receptor-2-positive breast cancer: A systematic review. PLoS One 2021;16:e0252925. [PMID: 34143813 DOI: 10.1371/journal.pone.0252925] [Reference Citation Analysis]
2 Mukkamalla SKR, Huynh DV, Somasundar PS, Rathore R. Adjuvant Chemotherapy and Tumor Sidedness in Stage II Colon Cancer: Analysis of the National Cancer Data Base. Front Oncol 2020;10:568417. [PMID: 33042845 DOI: 10.3389/fonc.2020.568417] [Reference Citation Analysis]
3 Lopez-Aguiar AG, Zaidi MY, Beal EW, Dillhoff M, Cannon JGD, Poultsides GA, Kanji ZS, Rocha FG, Marincola Smith P, Idrees K, Beems M, Cho CS, Fisher AV, Weber SM, Krasnick BA, Fields RC, Cardona K, Maithel SK. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group. Ann Surg Oncol. 2019;26:2517-2524. [PMID: 31004295 DOI: 10.1245/s10434-019-07367-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
4 Lee KY, Park JW, Lee KY, Cho S, Kwon YH, Kim MJ, Ryoo SB, Jeong SY, Park KJ. Oncologic outcomes after adjuvant chemotherapy with capecitabine compared to 5-fluorouracil/leucovorin for geriatric stage II colon cancer: a retrospective cohort study. Int J Colorectal Dis 2019;34:629-39. [PMID: 30661101 DOI: 10.1007/s00384-019-03237-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Han S, Wu W, Da M, Xu J, Zhuang J, Zhang L, Zhang X, Yang X. Adequate Lymph Node Assessments and Investigation of Gut Microorganisms and Microbial Metabolites in Colorectal Cancer. Onco Targets Ther 2020;13:1893-906. [PMID: 32184624 DOI: 10.2147/OTT.S242017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Cabo J, Shu X, Shu XO, Parikh A, Bailey C. Treatment at Academic Centers Decreases Insurance-Based Survival Disparities in Colon Cancer. Journal of Surgical Research 2020;245:265-72. [DOI: 10.1016/j.jss.2019.07.059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhou Z, Zhu H, Liu W, Tan F, Pei Q, Zhao L, Li C, Wang D, Zhou Y, Peng H, Pei H, Li Y. Has the increase in the regional nodes evaluated improved survival rates for patients with locoregional colon cancer? J Cancer 2021;12:2513-25. [PMID: 33854613 DOI: 10.7150/jca.52352] [Reference Citation Analysis]